Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Rosenbaum

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Harm Reduction Journal|July 11, 2019
Psychedelic microdosing benefits and challenges: an empirical codebookThomas Anderson, Rotem Petranker, Adam Christopher, et al.
The Journal of Biological Chemistry|January 8, 2011
The matricellular protein cysteine-rich protein 61 (CCN1/Cyr61) enhances physiological adaptation of retinal vessels and reduces pathological neovascularization associated with ischemic retinopathyAdeel Hasan, Nataliya Pokeza, Lynn Shaw, et al.
Biophysical Chemistry|April 10, 2023
Orexin A, an amphipathic α-helical neuropeptide involved in pleiotropic functions in the nervous and immune systems: Synthetic approach and biophysical studies of the membrane-bound stateHaydn L Ball, Hooda Said, Karen Chapman, et al.
Psychopharmacology|January 4, 2019
Microdosing psychedelics: personality, mental health, and creativity differences in microdosersThomas Anderson, Rotem Petranker, Daniel Rosenbaum, et al.
Annals of Palliative Medicine|May 21, 2024
Palliative psychiatry: research, clinical, and educational prioritiesSarah Levitt, Rachel B Cooper, Mona Gupta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2008
Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinomaGregory J Riely, Mark G Kris, Daniel Rosenbaum, et al.
CMAJ Open|October 7, 2015
Characteristics of patients receiving long-term opioid therapy for chronic noncancer pain: a cross-sectional survey of patients attending the Pain Management Centre at Hamilton General Hospital, Hamilton, OntarioJason W Busse, Hamza Mahmood, Bilal Maqbool, et al.
Stroke|March 6, 2010
Hepatocyte growth factor and the risk of ischemic stroke developing among postmenopausal women: results from the Women's Health InitiativeSwapnil N Rajpathak, Tao Wang, Sylvia Wassertheil-Smoller, et al.
Pilot and Feasibility Studies|October 29, 2025
Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) therapy for patients with advanced cancer: protocol for a multi-method feasibility trialCandice Richardson, Cindy Chan, Emily Macgregor, et al.
FEBS Letters|September 26, 2020
Structural and functional diversity calls for a new classification of ABC transportersChristoph Thomas, Stephen G Aller, Konstantinos Beis, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Harm Reduction Journal|July 11, 2019
Psychedelic microdosing benefits and challenges: an empirical codebookThomas Anderson, Rotem Petranker, Adam Christopher, et al.
The Journal of Biological Chemistry|January 8, 2011
The matricellular protein cysteine-rich protein 61 (CCN1/Cyr61) enhances physiological adaptation of retinal vessels and reduces pathological neovascularization associated with ischemic retinopathyAdeel Hasan, Nataliya Pokeza, Lynn Shaw, et al.
Biophysical Chemistry|April 10, 2023
Orexin A, an amphipathic α-helical neuropeptide involved in pleiotropic functions in the nervous and immune systems: Synthetic approach and biophysical studies of the membrane-bound stateHaydn L Ball, Hooda Said, Karen Chapman, et al.
Psychopharmacology|January 4, 2019
Microdosing psychedelics: personality, mental health, and creativity differences in microdosersThomas Anderson, Rotem Petranker, Daniel Rosenbaum, et al.
Annals of Palliative Medicine|May 21, 2024
Palliative psychiatry: research, clinical, and educational prioritiesSarah Levitt, Rachel B Cooper, Mona Gupta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2008
Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinomaGregory J Riely, Mark G Kris, Daniel Rosenbaum, et al.
CMAJ Open|October 7, 2015
Characteristics of patients receiving long-term opioid therapy for chronic noncancer pain: a cross-sectional survey of patients attending the Pain Management Centre at Hamilton General Hospital, Hamilton, OntarioJason W Busse, Hamza Mahmood, Bilal Maqbool, et al.
Stroke|March 6, 2010
Hepatocyte growth factor and the risk of ischemic stroke developing among postmenopausal women: results from the Women's Health InitiativeSwapnil N Rajpathak, Tao Wang, Sylvia Wassertheil-Smoller, et al.
Pilot and Feasibility Studies|October 29, 2025
Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) therapy for patients with advanced cancer: protocol for a multi-method feasibility trialCandice Richardson, Cindy Chan, Emily Macgregor, et al.
FEBS Letters|September 26, 2020
Structural and functional diversity calls for a new classification of ABC transportersChristoph Thomas, Stephen G Aller, Konstantinos Beis, et al.
Pageof 2